ArticleNeuro-oncology advances

Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival.

Cymon N Kersch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.